Zobrazeno 1 - 10
of 20
pro vyhledávání: '"EQ Crusoé"'
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S514-S515 (2024)
Aims: To characterize the genomic and transcriptomic profiles associated with t(11;14) status in NDMM and RRMM. Methods: The global, non-interventional MEDICI study (NCT04721002) enrolled pts aged ≥18 years who provided informed consent and had BM
Externí odkaz:
https://doaj.org/article/4396d5cea2fa488b825b5469803484bd
Autor:
BM Ferraz, MIS Perdiz, DMS Ferreira, BG Silva, MA Salvino, MBV Lima, CAR Pina, EQ Crusoé, MA Dias, L Aragão
Publikováno v:
Hematology, Transfusion and Cell Therapy. 44:S239-S240
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2dd0a6b7208f0939ad94c1e3c0c15564
https://doi.org/10.1016/j.htct.2022.09.405
https://doi.org/10.1016/j.htct.2022.09.405
Autor:
MIS Perdiz, BM Ferraz, DMS Ferreira, BG Silva, JA Santos, MA Dias, CV Vignal, EQ Crusoé, MAS Araujo
Publikováno v:
Hematology, Transfusion and Cell Therapy. 44:S122-S123
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f5b6981d4660cc2fda0106b517922e7
https://doi.org/10.1016/j.htct.2022.09.206
https://doi.org/10.1016/j.htct.2022.09.206
Autor:
MBV Lima, EP Noronha, EQ Crusoe, MA Salvino, FSBF Chagas, GA Oliveira, SN Freitas, JFSD Carmo, LKN Canuto, LBD Santos
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S415- (2024)
Introdução: A combinação do inibidor de BCL-2, Venetoclax (VEN), com poliquimioterapia tem sido explorada no tratamento da Leucemia Mieloide Aguda (LMA), especialmente em pacientes recidivados ou refratários (R/R). Estudos anteriores indicam que
Externí odkaz:
https://doaj.org/article/53c952aa7f5349d898da9c332fa582e2
Autor:
EQ Crusoe, AV Glasenapp, GN Ribeiro, L Perobelli, P Ochoa, FVP Souza, S Lopresti, JS Filho, C Pena, V Hungria
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S528- (2024)
Introduction: Smoldering multiple myeloma (SMM) is an asymptomatic clonal plasma cell disorder with a prevalence of 0.5% in the > 40 yrs population. Effort has been made to characterize these patients in the real world. There is scarce data about SMM
Externí odkaz:
https://doaj.org/article/5581ddfdff9f4327a96732c14fc12ef7
Autor:
EQ Crusoe, GN Ribeiro, FL Moura, AC Neto, M Aranha, RI Bittencourt, EF Ribeiro, JVP Neto, A Maiolino, V Hungria
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S527-S528 (2024)
Background: The standard approach to autologous stem cell transplantation (ASCT) in patients with newly diagnosed multiple myeloma (NDMM) included induction and maintenance until progression. The newest induction protocol that had included daratumuma
Externí odkaz:
https://doaj.org/article/c27bf5f63cb047119766df3d07e4be93
Autor:
EQ Crusoé, JSLRD Santos, JAD Santos, HHM Santos, AS Santos, LF Lucas, AM Almeida, VT Hungria, MA Salvino, MGB Arruda
Publikováno v:
Hematology, Transfusion and Cell Therapy. 44:S267
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::612632e643361f390a2788dbc6b0a7d1
https://doi.org/10.1016/j.htct.2022.09.451
https://doi.org/10.1016/j.htct.2022.09.451
Autor:
EQ Crusoe, J Santos, J Leal, H Santos, A Almeida, L Lucas, M Chaves, V Hungria, M Salvino, MG Arruda
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S194-S195 (2021)
Background: Newly drugs access for MM treatment still a challenge in some countries. One of the most availableinductions for TE NDMM patients (pts) worldwide is cyclophosphamide (C), thalidomide (T) and dexamethasone (d)-(CTd). Dara the first anti- C
Externí odkaz:
https://doaj.org/article/1ce53fea041e4e57be0afd82bb4483ec
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S215- (2021)
Objectives: Systemic AL amyloidosis is a plasma cell disease characterized by the deposition of insoluble amyloid fibrils causing organ dysfunction and death. Primary results from the ANDROMEDA study showed that addition of subcutaneous (SC) daratumu
Externí odkaz:
https://doaj.org/article/b879cce990a54aca94951c7640f46bc1
Autor:
EQ Crusoe, A Moura, M Chaves, M Salvino, J Santos, H Santos, A Santos, L Lucas, J Leal, MG Arruda
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S261-S262 (2021)
Background: The combination of an anti-CD38 monoclonal antibody, Dara, to the main induction protocols (VRd, VTd,VCd) significantly improved the response rate of TE NDMM before transplantation. However, there is a concern regardingthe possible interf
Externí odkaz:
https://doaj.org/article/dc70877470794cb1a341b115d0d7b621